CTNNB1 and renal dysplasia: Taken together, these studies demonstrate that quercetin reduces nuclear beta-catenin and transcriptional activity resulting in improved outcomes in disease models and is therefore an ideal candidate to determine its therapeutic effects on renal dysplasia caused by abnormal nuclear beta-catenin levels and activity.